{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T08:49:50Z","timestamp":1787820590072,"version":"build-2784847793"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Biological Macromolecules"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1016\/j.ijbiomac.2019.09.157","type":"journal-article","created":{"date-parts":[[2019,11,11]],"date-time":"2019-11-11T11:52:29Z","timestamp":1573473149000},"page":"968-976","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Degraded fucoidan fractions and \u03b2-1,3-glucan sulfates inhibit CXCL12-induced Erk1\/2 activation and chemotaxis in Burkitt lymphoma cells"],"prefix":"10.1016","volume":"143","author":[{"given":"Inga","family":"Techel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Lahrsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanne","family":"Alban","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijbiomac.2019.09.157_b0005","doi-asserted-by":"crossref","DOI":"10.3390\/md17010032","article-title":"Fucoidan structure and activity in relation to anti-cancer mechanisms","volume":"17","author":"van Weelden","year":"2019","journal-title":"Mar. Drugs"},{"key":"10.1016\/j.ijbiomac.2019.09.157_b0010","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s00253-011-3666-8","article-title":"Algal fucoidan: structural and size-dependent bioactivities and their perspectives","volume":"93","author":"Morya","year":"2012","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"10.1016\/j.ijbiomac.2019.09.157_b0015","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1093\/glycob\/cwn085","article-title":"Structure, biology, evolution, and medical importance of sulfated fucans and galactans","volume":"18","author":"Pomin","year":"2008","journal-title":"Glycobiology"},{"key":"10.1016\/j.ijbiomac.2019.09.157_b0020","doi-asserted-by":"crossref","first-page":"76","DOI":"10.3390\/md13010076","article-title":"Sulfated galactofucan from the brown Alga Saccharina latissima-variability of yield, structural composition and bioactivity","volume":"13","author":"Ehrig","year":"2014","journal-title":"Mar. Drugs"},{"key":"10.1016\/j.ijbiomac.2019.09.157_b0025","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1093\/glycob\/cwv022","article-title":"Interference with the CXCL12\/CXCR4 axis as potential antitumor strategy: superiority of a sulfated galactofucan from the brown alga Saccharina latissima and fucoidan over heparins","volume":"25","author":"Schneider","year":"2015","journal-title":"Glycobiology"},{"key":"10.1016\/j.ijbiomac.2019.09.157_b0030","doi-asserted-by":"crossref","first-page":"851","DOI":"10.3390\/md12020851","article-title":"Fucoidan as a marine anticancer agent in preclinical development","volume":"12","author":"Kwak","year":"2014","journal-title":"Mar. Drugs"},{"key":"10.1016\/j.ijbiomac.2019.09.157_b0035","doi-asserted-by":"crossref","first-page":"5920","DOI":"10.3390\/md13095920","article-title":"Therapies from Fucoidan: an update","volume":"13","author":"Fitton","year":"2015","journal-title":"Mar. Drugs"},{"key":"10.1016\/j.ijbiomac.2019.09.157_b0040","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.3390\/md13041882","article-title":"Prophylactic administration of fucoidan represses cancer metastasis by inhibiting vascular endothelial growth factor (VEGF) and matrix metalloproteinases (MMPs) in Lewis tumor-bearing mice","volume":"13","author":"Huang","year":"2015","journal-title":"Mar. Drugs"},{"key":"10.1016\/j.ijbiomac.2019.09.157_b0045","doi-asserted-by":"crossref","DOI":"10.1093\/abbs\/gmv094","article-title":"Antitumor activity of fucoidan against diffuse large B cell lymphoma in vitro and in vivo","author":"Yang","year":"2015","journal-title":"Acta Biochim. Biophys. Sin."},{"key":"10.1016\/j.ijbiomac.2019.09.157_b0050","doi-asserted-by":"crossref","first-page":"2327","DOI":"10.3390\/md13042327","article-title":"Fucoidan and cancer","volume":"13","author":"Atashrazm","year":"2015","journal-title":"Mar. Drugs"},{"key":"10.1016\/j.ijbiomac.2019.09.157_b0055","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.carbpol.2017.09.005","article-title":"The potential of brown-algae polysaccharides for the development of anticancer agents","volume":"177","author":"Sanjeewa","year":"2017","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.ijbiomac.2019.09.157_b0060","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.carbpol.2017.02.051","article-title":"Effects of fucoidans and heparin on reactions of neutrophils induced by IL-8 and C5a","volume":"165","author":"Liewert","year":"2017","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.ijbiomac.2019.09.157_b0065","doi-asserted-by":"crossref","first-page":"18763","DOI":"10.18632\/oncotarget.7708","article-title":"PDZ-binding kinase\/T-LAK cell-originated protein kinase is a target of the fucoidan from brown alga Fucus evanescens in the prevention of EGF-induced neoplastic cell transformation and colon cancer growth","volume":"7","author":"Vishchuk","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.ijbiomac.2019.09.157_b0070","doi-asserted-by":"crossref","DOI":"10.3390\/md17050258","article-title":"Effects of fucoidans from five different brown algae on oxidative stress and VEGF interference in ocular cells","volume":"17","author":"D\u00f6rschmann","year":"2019","journal-title":"Mar. Drugs"},{"key":"10.1016\/j.ijbiomac.2019.09.157_b0075","doi-asserted-by":"crossref","DOI":"10.3390\/cells8020185","article-title":"Involvement of CXCR4 in normal and abnormal development","volume":"8","author":"Kawaguchi","year":"2019","journal-title":"Cells"},{"key":"10.1016\/j.ijbiomac.2019.09.157_b0080","unstructured":"ClinicalTrials.gov Database, https:\/\/clinicaltrials.gov\/, 2019 (accessed 10 April 2019)."},{"key":"10.1016\/j.ijbiomac.2019.09.157_b0085","doi-asserted-by":"crossref","first-page":"77S","DOI":"10.2967\/jnumed.116.186874","article-title":"CXCR4 ligands","volume":"58","author":"Walenkamp","year":"2017","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.ijbiomac.2019.09.157_b0090","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.imlet.2016.06.006","article-title":"CXCR4 signaling in health and disease","volume":"177","author":"Pozzobon","year":"2016","journal-title":"Immunol. Lett."},{"key":"10.1016\/j.ijbiomac.2019.09.157_b0095","first-page":"1347","article-title":"Emerging targets in cancer management: role of the CXCL12\/CXCR4 axis","volume":"6","author":"Cojoc","year":"2013","journal-title":"Onco. Targets Ther. (OncoTargets and therapy)"},{"key":"10.1016\/j.ijbiomac.2019.09.157_b0100","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.ejca.2012.05.005","article-title":"A review on CXCR4\/CXCL12 axis in oncology: no place to hide","volume":"49","author":"Domanska","year":"2013","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.ijbiomac.2019.09.157_b0105","series-title":"Heparin: A Century of Progress","first-page":"211","article-title":"Adverse effects of heparin","author":"Alban","year":"2012"},{"key":"10.1016\/j.ijbiomac.2019.09.157_b0110","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.2174\/138161208784246135","article-title":"Pharmacological strategies for inhibition of thrombin activity","volume":"14","author":"Alban","year":"2008","journal-title":"CPD"},{"key":"10.1016\/j.ijbiomac.2019.09.157_b0115","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1021\/acsbiomaterials.8b01113","article-title":"Degradation of eight sulfated polysaccharides extracted from red and brown algae and its impact on structure and pharmacological activities","volume":"5","author":"Lahrsen","year":"2019","journal-title":"ACS Biomater. Sci. Eng."},{"key":"10.1016\/j.ijbiomac.2019.09.157_b0120","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.carbpol.2018.03.056","article-title":"Gradual degradation of fucoidan from Fucus vesiculosus and its effect on structure, antioxidant and antiproliferative activities","volume":"192","author":"Lahrsen","year":"2018","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.ijbiomac.2019.09.157_b0125","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1021\/bm010032u","article-title":"Partial synthetic glucan sulfates as potential new antithrombotics: a review","volume":"2","author":"Alban","year":"2001","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.ijbiomac.2019.09.157_b0130","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1055\/s-2007-1001898","article-title":"Gas-liquid chromatography-mass spectrometry analysis of anticoagulant active curdlan sulfates","volume":"20","author":"Alban","year":"1994","journal-title":"Semin. Thromb. Hemost."},{"key":"10.1016\/j.ijbiomac.2019.09.157_b0135","unstructured":"Laboratoires Goemar, Phycarine, 614768 (23.09.1993)."},{"key":"10.1016\/j.ijbiomac.2019.09.157_b0140","first-page":"1005","article-title":"Synthesis of laminarin sulfates with anticoagulant activity","volume":"42","author":"Alban","year":"1992","journal-title":"Arzneimittel-Forschung"},{"key":"10.1016\/j.ijbiomac.2019.09.157_b0145","unstructured":"J.-C. Yvin, S. Alban, G. Franz, Anti-inflammatory and healing medicine based on laminarin sulphate, US 7,008,931-B2 (07.03.2006), EP 1337261-B1 (21.03.2007)."},{"key":"10.1016\/j.ijbiomac.2019.09.157_b0150","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1177\/108705710100600605","article-title":"Development of SPC-ELISA","volume":"6","author":"Alban","year":"2001","journal-title":"J. Biomol. Screen."},{"key":"10.1016\/j.ijbiomac.2019.09.157_b0155","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.3390\/md12042205","article-title":"Simple and rapid quality control of sulfated glycans by a fluorescence sensor assay\u2013exemplarily developed for the sulfated polysaccharides from red algae Delesseria sanguinea","volume":"12","author":"L\u00fchn","year":"2014","journal-title":"Mar. Drugs"},{"key":"10.1016\/j.ijbiomac.2019.09.157_b0160","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1021\/bm8014158","article-title":"Evaluation of seasonal variations of the structure and anti-inflammatory activity of sulfated polysaccharides extracted from the red alga Delesseria sanguinea (Hudson) Lamouroux (Ceramiales, Delesseriaceae)","volume":"10","author":"Gr\u00fcnewald","year":"2009","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.ijbiomac.2019.09.157_b0165","doi-asserted-by":"crossref","first-page":"2998","DOI":"10.1021\/bm900501g","article-title":"Optimized and standardized isolation and structural characterization of anti-inflammatory sulfated polysaccharides from the red alga Delesseria sanguinea (Hudson) Lamouroux (Ceramiales, Delesseriaceae)","volume":"10","author":"Gr\u00fcnewald","year":"2009","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.ijbiomac.2019.09.157_b0170","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1038\/227680a0","article-title":"Cleavage of structural proteins during the assembly of the head of bacteriophage T4","volume":"227","author":"Laemmli","year":"1970","journal-title":"Nature"},{"key":"10.1016\/j.ijbiomac.2019.09.157_b0175","doi-asserted-by":"crossref","first-page":"4350","DOI":"10.1073\/pnas.76.9.4350","article-title":"Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications","volume":"76","author":"Towbin","year":"1979","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ijbiomac.2019.09.157_b0180","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.aanat.2012.10.013","article-title":"An infernal trio: the chemokine CXCL12 and its receptors CXCR4 and CXCR7 in tumor biology","volume":"195","author":"Hattermann","year":"2013","journal-title":"Ann. Anat."},{"key":"10.1016\/j.ijbiomac.2019.09.157_b0185","doi-asserted-by":"crossref","first-page":"2201","DOI":"10.1084\/jem.20052144","article-title":"A novel chemokine receptor for SDF-1 and I-TAC involved in cell survival, cell adhesion, and tumor development","volume":"203","author":"Burns","year":"2006","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.ijbiomac.2019.09.157_b0190","doi-asserted-by":"crossref","first-page":"35760","DOI":"10.1074\/jbc.M508234200","article-title":"The chemokine SDF-1\/CXCL12 binds to and signals through the orphan receptor RDC1 in T lymphocytes","volume":"280","author":"Balabanian","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ijbiomac.2019.09.157_b0195","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.carbpol.2016.08.005","article-title":"A review about the development of fucoidan in antitumor activity: progress and challenges","volume":"154","author":"Wu","year":"2016","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.ijbiomac.2019.09.157_b0200","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.carbpol.2018.02.035","article-title":"Size-dependent pharmacological activities of differently degraded fucoidan fractions from Fucus vesiculosus","volume":"189","author":"Lahrsen","year":"2018","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.ijbiomac.2019.09.157_b0205","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0165493","article-title":"Regulation of complement and contact system activation via C1 inhibitor potentiation and factor XIIa activity modulation by sulfated glycans - structure-activity relationships","volume":"11","author":"Schoenfeld","year":"2016","journal-title":"PloS one"},{"key":"10.1016\/j.ijbiomac.2019.09.157_b0210","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/S0049-3848(00)00338-8","article-title":"Relationship between sulfate groups and biological activities of fucans","volume":"100","author":"Haroun-Bouhedja","year":"2000","journal-title":"Thromb. Res."},{"key":"10.1016\/j.ijbiomac.2019.09.157_b0215","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1128\/JVI.80.2.866-874.2006","article-title":"Hepatitis C virus induces toll-like receptor 4 expression, leading to enhanced production of beta interferon and interleukin-6","volume":"80","author":"Machida","year":"2006","journal-title":"J. Virol."},{"key":"10.1016\/j.ijbiomac.2019.09.157_b0220","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/s10517-012-1922-2","article-title":"Interactions between sulfated polysaccharides from sea brown algae and Toll-like receptors on HEK293 eukaryotic cells in vitro","volume":"154","author":"Makarenkova","year":"2012","journal-title":"Bull. Exp. Biol. Med."},{"key":"10.1016\/j.ijbiomac.2019.09.157_b0225","doi-asserted-by":"crossref","first-page":"318","DOI":"10.18097\/pbmc20125803318","article-title":"Sulfated polysaccharides of brown seaweeds\u2013ligands of toll-like receptors","volume":"58","author":"Makarenkova","year":"2012","journal-title":"Biomed. Khim."},{"key":"10.1016\/j.ijbiomac.2019.09.157_b0230","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.imbio.2016.06.009","article-title":"Toll-like receptor stimulation in cancer","volume":"222","author":"Dajon","year":"2017","journal-title":"Immunobiology"},{"key":"10.1016\/j.ijbiomac.2019.09.157_b0235","article-title":"The cancer prevention, anti-inflammatory and anti-oxidation of bioactive phytochemicals targeting the TLR4 signaling pathway","volume":"19","author":"Chen","year":"2018","journal-title":"Int. J. Mol. Sci."}],"container-title":["International Journal of Biological Macromolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813019352791?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813019352791?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T07:46:59Z","timestamp":1758872819000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0141813019352791"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":47,"alternative-id":["S0141813019352791"],"URL":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2019.09.157","relation":{},"ISSN":["0141-8130"],"issn-type":[{"value":"0141-8130","type":"print"}],"subject":[],"published":{"date-parts":[[2020,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Degraded fucoidan fractions and \u03b2-1,3-glucan sulfates inhibit CXCL12-induced Erk1\/2 activation and chemotaxis in Burkitt lymphoma cells","name":"articletitle","label":"Article Title"},{"value":"International Journal of Biological Macromolecules","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2019.09.157","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}